Cite
TNEA therapy promotes the autophagic degradation of NLRP3 inflammasome in a transgenic mouse model of Alzheimer's disease via TFEB/TFE3 activation.
MLA
Lin, Wenjia, et al. “TNEA Therapy Promotes the Autophagic Degradation of NLRP3 Inflammasome in a Transgenic Mouse Model of Alzheimer’s Disease via TFEB/TFE3 Activation.” Journal of Neuroinflammation, vol. 20, no. 1, Feb. 2023, pp. 1–16. EBSCOhost, https://doi.org/10.1186/s12974-023-02698-w.
APA
Lin, W., Li, Z., Liang, G., Zhou, R., Zheng, X., Tao, R., Huo, Q., Su, C., Li, M., Xu, N., Tang, C., & Song, J.-X. (2023). TNEA therapy promotes the autophagic degradation of NLRP3 inflammasome in a transgenic mouse model of Alzheimer’s disease via TFEB/TFE3 activation. Journal of Neuroinflammation, 20(1), 1–16. https://doi.org/10.1186/s12974-023-02698-w
Chicago
Lin, Wenjia, Zhao Li, Guangfeng Liang, Runjin Zhou, Xiaoyan Zheng, Rongrong Tao, Qingwei Huo, et al. 2023. “TNEA Therapy Promotes the Autophagic Degradation of NLRP3 Inflammasome in a Transgenic Mouse Model of Alzheimer’s Disease via TFEB/TFE3 Activation.” Journal of Neuroinflammation 20 (1): 1–16. doi:10.1186/s12974-023-02698-w.